Effect of Giving Papaya Leaf Extract (Carica Papaya L.) on Changes in Fasting Blood Glucose in Male Wistar Rats (Rattus Norvegicus) Induced by Streptozotocin
Main Article Content
Abstract
Background: Diabetes mellitus is a disease characterized by an increase in blood glucose levels due to decreased insulin production or decreased insulin action. Diabetes cases are described as a serious problem globally in the 21st century and cases are increasing worldwide. One type of plant that can be used as a medicine is papaya leaf (Carica papaya L.) which is known to contain several active compounds such as flavonoids, saponins, tannins, and alkaloids. Objective: To determine the effect of papaya leaf extract (Carica papaya L.) on changes in fasting blood glucose levels of male Wistar rats with hyperglycemia conditions. Methodology: This research is an experimental research Randomized Controlled Trial (RCT) with Pretest-Postest Group Design study design. This study used 35 male white rats which were divided into 5 groups. Group I (without treatment), group II (STZ-NA), group III (STZ-NA and Glimepiride), group IV (papaya leaf extract at a dose of 150mg/Kg), group V (papaya leaf extract at a dose of 200mg/Kg). The data obtained after the study will be tested for normality which is then continued with non-parametric tests using the Kruskal-Wallis and Mann-Whitney U tests, and an effect size test is carried out to determine how much effect is produced from the papaya leaf extract given. Research Results: The administration of papaya leaf extract at a dose of 200mg/200grBody Weight in male Wistar rats in group 5 proved to reduce fasting blood glucose levels more significantly than the administration of glimepiride at a dose of 0.04 mg and papaya leaf extract at a dose of 150mg/Kg. Conclusion: Administration of papaya leaf extract (Carica papaya L.) can reduce fasting blood glucose levels in diabetic model rats effectively at a dose of 200mg/Kg.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Chaudhury, A., Duvoor, C., Reddy Dendi, V. S., Kraleti, S., Chada, A., Ravilla, R., Marco, A., Shekhawat, N. S., Montales, M. T., Kuriakose, K., Sasapu, A., Beebe, A., Patil, N., Musham, C. K., Lohani, G. P., & Mirza, W. (2017). Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Frontiers in Endocrinology, 8(January).
https://doi.org/10.3389/fendo.2017.00006
II. Fatimah, R. N. (2015). Diabetes Melitus Tipe 2. 4, 93–101. https://juke.kedokteran.unila.ac.id/index.php/majority/article/viewFile/615/619
III. Harijanto, E. A., & Dewajanti, A. M. (2017). Optimalisasi Pemberian Streptozotocin Beberapa Dosis terhadap Peningkatan Kadar Gula Darah Tikus Sprague dawley. Jurnal Kedokteran Meditek, 23(63), 12–18.
http://ejournal.ukrida.ac.id/ojs/index.php/Meditek/article/view/1559
IV. Hidayat, B., Ramadani, R. V., Rudijanto, A., Soewondo, P., Suastika, K., & Siu Ng, J. Y. (2022). Direct Medical Cost of Type 2 Diabetes Mellitus and Its Associated Complications in Indonesia. Value in Health Regional Issues, 28, 82–89. https://doi.org/10.1016/j.vhri.2021.04.006
V. Juárez-Rojop, I. E., Tovilla-Zárate, C. A., Aguilar-Domínguez, D. E., Fuente, L. F. R. de la, Lobato-García, C. E., Blé-Castillo, J. L., López-Meraz, L., Díaz-Zagoya, J. C., & Bermúdez-Ocaña, D. Y. (2014). Phytochemical screening and hypoglycemic activity of carica papaya leaf in streptozotocin-induced diabetic rats. In Revista Brasileira de Farmacognosia (Vol. 24, Issue 3, pp. 341–347). https://doi.org/10.1016/j.bjp.2014.07.012
VI. Marsha L. Tracey, Michael Gilmartin, Kate O’Neill, Anthony P. Fitzgerald, Sheena M. MCHugh, Claire M. Buckley, Ronan J. Canavan, & Kearney, P. M. (2016). Epidemiology of diabetes and complications among adults in the Republic of Ireland 1998-2015.
VII. Nyakundi, B. B., & Yang, J. (2023). Uses of Papaya Leaf and Seaweed Supplementations for Controlling Glucose Homeostasis in Diabetes. International Journal of Molecular Sciences, 24(7).
https://doi.org/10.3390/ijms24076846
VIII. Roy, J. R., Janaki, C. S., Jayaraman, S., Periyasamy, V., Balaji, T., Vijayamalathi, M., & Veeraraghavan, V. P. (2022). Carica papaya Reduces Muscle Insulin Resistance via IR/GLUT4 Mediated Signaling Mechanisms in High Fat Diet and Streptozotocin-Induced Type-2 Diabetic Rats. Antioxidants, 11(10), 1–25. https://doi.org/10.3390/antiox11102081
IX. Singh, S. P., Kumar, S., Mathan, S. V., Tomar, M. S., Singh, R. K., Verma, P. K., Kumar, A., Kumar, S., Singh, R. P., & Acharya, A. (2020). Therapeutic application of Carica papaya leaf extract in the management of human diseases. DARU, Journal of Pharmaceutical Sciences, 28(2), 735–744. https://doi.org/10.1007/s40199-020-00348-7
X. Solikhah, T. I., Setiawan, B., & Ismukada, D. R. (2020). Antidiabetic activity of papaya leaf extract (Carica Papaya L.) isolated with maceration method in alloxan-induces diabetic mice. Systematic Reviews in Pharmacy, 11(9), 774–778.
https://doi.org/10.31838/srp.2020.9.109
XI. Trerattanavong, K., & Tadi, P. (2023). Glimepiride. 10–13.
XII. WHO. (2019). Classification Of Diabetes Mellitus. http://apps.who.int/bookorders.